AMY YENTSCH: Open Payments
NPI 1922556117 · ABINGTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 9 payments from 7 companies in 2025. Trend: 2023 $1,327 · 2024 $962 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $130 |
| Teva Pharmaceuticals USA, Inc. | 2 | $119 |
| Axsome Therapeutics, Inc. | 2 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $116 |
| Hologic Sales and Service, LLC | 1 | $101 |
| Indivior Inc. | 1 | $79 |
| Braeburn Inc. | 1 | $18 |
Products named: Epclusa, AUSTEDO XR, Auvelity, CAPLYTA, APTIMA, SUBLOCADE, BRIXADI.
Industry payments across MA — which companies pay providers there.
